Cargando…

MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer

Dysregulated microRNAs (miRNAs) have been implicated in the pathogenic processes of colon cancer. Epithelial mesenchymal transition (EMT) promotes metastatic progression and cancer stem cells are closely involved in colon cancer proliferation and metastasis. Functional effects of miR-377 on colon ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Shayimu, Paerhati, Yusufu, Aikeremu, Rehemutula, Aizimaiti, Redati, Darebai, Jiapaer, Rexida, Tuerdi, Rousidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588759/
https://www.ncbi.nlm.nih.gov/pubmed/33084522
http://dx.doi.org/10.1177/1533033820967475
_version_ 1783600430916304896
author Shayimu, Paerhati
Yusufu, Aikeremu
Rehemutula, Aizimaiti
Redati, Darebai
Jiapaer, Rexida
Tuerdi, Rousidan
author_facet Shayimu, Paerhati
Yusufu, Aikeremu
Rehemutula, Aizimaiti
Redati, Darebai
Jiapaer, Rexida
Tuerdi, Rousidan
author_sort Shayimu, Paerhati
collection PubMed
description Dysregulated microRNAs (miRNAs) have been implicated in the pathogenic processes of colon cancer. Epithelial mesenchymal transition (EMT) promotes metastatic progression and cancer stem cells are closely involved in colon cancer proliferation and metastasis. Functional effects of miR-377 on colon cancer stem cell phenotypes and EMT were then determined in the present study. Firstly, reduced miR-377 was found in colon cancer tissues and cell lines. Results from flow cytometry, sphere formation and western blot assays showed that miR-377 knockdown increased number of ALDH+ cells and promoted sphere formation ability. Moreover, cell migration/invasion and EMT of colon cancer cells were suppressed by miR-377 over-expression. On the contrary, miR-377 mimics caused the reversed results. ZEB2 (zinc finger E box-binding homeobox 2) was then validated as a binding target of miR-377. ZEB2 over-expression reversed the inhibitory abilities of miR-377 on cancer stem cell phenotypes, EMT, migration and invasion. In conclusion, miR-377 regulates cancer stem cell phenotypes and EMT in colon cancer cells via regulation of ZEB2, suggesting a new therapeutic strategy for colon cancer treatment.
format Online
Article
Text
id pubmed-7588759
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-75887592020-11-09 MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer Shayimu, Paerhati Yusufu, Aikeremu Rehemutula, Aizimaiti Redati, Darebai Jiapaer, Rexida Tuerdi, Rousidan Technol Cancer Res Treat Original Article Dysregulated microRNAs (miRNAs) have been implicated in the pathogenic processes of colon cancer. Epithelial mesenchymal transition (EMT) promotes metastatic progression and cancer stem cells are closely involved in colon cancer proliferation and metastasis. Functional effects of miR-377 on colon cancer stem cell phenotypes and EMT were then determined in the present study. Firstly, reduced miR-377 was found in colon cancer tissues and cell lines. Results from flow cytometry, sphere formation and western blot assays showed that miR-377 knockdown increased number of ALDH+ cells and promoted sphere formation ability. Moreover, cell migration/invasion and EMT of colon cancer cells were suppressed by miR-377 over-expression. On the contrary, miR-377 mimics caused the reversed results. ZEB2 (zinc finger E box-binding homeobox 2) was then validated as a binding target of miR-377. ZEB2 over-expression reversed the inhibitory abilities of miR-377 on cancer stem cell phenotypes, EMT, migration and invasion. In conclusion, miR-377 regulates cancer stem cell phenotypes and EMT in colon cancer cells via regulation of ZEB2, suggesting a new therapeutic strategy for colon cancer treatment. SAGE Publications 2020-10-21 /pmc/articles/PMC7588759/ /pubmed/33084522 http://dx.doi.org/10.1177/1533033820967475 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Shayimu, Paerhati
Yusufu, Aikeremu
Rehemutula, Aizimaiti
Redati, Darebai
Jiapaer, Rexida
Tuerdi, Rousidan
MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer
title MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer
title_full MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer
title_fullStr MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer
title_full_unstemmed MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer
title_short MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer
title_sort microrna-377 counteracts with cancer stem cell phenotypes and epithelial mesenchymal transformation by targeting zeb2 in colon cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588759/
https://www.ncbi.nlm.nih.gov/pubmed/33084522
http://dx.doi.org/10.1177/1533033820967475
work_keys_str_mv AT shayimupaerhati microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer
AT yusufuaikeremu microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer
AT rehemutulaaizimaiti microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer
AT redatidarebai microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer
AT jiapaerrexida microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer
AT tuerdirousidan microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer